SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-270979
Filing Date
2022-10-27
Accepted
2022-10-27 16:20:06
Documents
14
Period of Report
2022-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d409394d8k.htm   iXBRL 8-K 28160
2 EX-99.1 d409394dex991.htm EX-99.1 12758
6 GRAPHIC g409394g08w20.jpg GRAPHIC 11878
  Complete submission text file 0001193125-22-270979.txt   181015

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agio-20221027.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20221027_lab.xml EX-101.LAB 17238
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20221027_pre.xml EX-101.PRE 10803
8 EXTRACTED XBRL INSTANCE DOCUMENT d409394d8k_htm.xml XML 3230
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 221337559
SIC: 2834 Pharmaceutical Preparations